Current filters:

Bromocriptine Mesylate

1 to 9 of 23 results

J&J To Cut 4,100 Jobs, Taking $800 Million Charge


US health care major Johnson & Johnson has announced a restructuringplan that will lead to the loss of…

Bromocriptine MesylateCladribineDopamineDopamine HydrochlorideJohnson & JohnsonLeustatinNystatinOralParlodelRoche

Bromocriptine For Obesity


Ergo Science has completed enrollment in its 300-patient Phase II studyof Ergoset (bromocriptine mesylate)…

Bromocriptine MesylateParlodel

Preclinical Data Provide Support For Ergoset


Data from preclinical studies of Ergo Science's drug for type IIdiabetes, Ergoset (bromocriptine mesylate),…

Bromocriptine MesylateParlodel

J&J Hooks Up With Ergo For Bromocriptine


Ergo Science has licensed worldwide rights to its oral dopamine agonistfor non-insulin-dependent diabetes,…

Bromocriptine MesylateDopamineDopamine HydrochlorideHumulin 70-30Humulin NHumulin RInsulinJohnson & JohnsonNystatinOralParlodel

French Reimbursable Delistings


Deletions of pharmaceutical products from France's official reimbursablespecialties list, made under…

AstemizoleBromocriptine MesylateHismanalJanssen-CilagParlodelSandoz

Sandoz To License Orion Parkinson's Drug


Sandoz has licensed worldwide rights to a Parkinson's disease drug developed by Orion Pharma of Finland,…

Bromocriptine MesylateCarbidopaCarbidopa-LevodopaComtanDoparEldeprylEntacaponeLevodopaLodosynMerck KGaAOrion PharmaParlodelRocheSandozSelegiline HclSinemet

1 to 9 of 23 results

Back to top